180 related articles for article (PubMed ID: 37409273)
1. Preliminary study of anti-CD40 and ubiquitin proteasome antibodies in primary podocytopaties.
Chebotareva N; Cao V; Vinogradov A; Alentov I; Sergeeva N; Kononikhin A; Moiseev S
Front Med (Lausanne); 2023; 10():1189017. PubMed ID: 37409273
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional study of antibodies to ubiquitin proteasome system in different glomerulopathies.
Chebotareva N; Cao V; Vinogradov A; Alentov I; Sergeeva N; Kononikhin A; Moiseev S
Clin Nephrol; 2023 Feb; 99(2):78-84. PubMed ID: 36472403
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of anti-nephrin antibodies in podocytopaties among adults.
Chebotareva N; Vinogradov A; Birukova Y; Alentov I; Sergeeva N; Chemodanova D; Kononikhin AS; Moiseev SV
Nephrology (Carlton); 2024 Feb; 29(2):86-92. PubMed ID: 37864506
[TBL] [Abstract][Full Text] [Related]
4. Podocin and beta dystroglycan expression to study podocyte-podocyte and basement membrane matrix connections in adult protienuric states.
Shankar PB; Nada R; Joshi K; Kumar A; Rayat CS; Sakhuja V
Diagn Pathol; 2014 Feb; 9():40. PubMed ID: 24559085
[TBL] [Abstract][Full Text] [Related]
5. UCH-L1 expression of podocytes in diseased glomeruli and in vitro.
Liu Y; Wu J; Wu H; Wang T; Gan H; Zhang X; Liu Y; Li R; Zhao Z; Chen Q; Guo M; Zhang Z
J Pathol; 2009 Apr; 217(5):642-53. PubMed ID: 19214988
[TBL] [Abstract][Full Text] [Related]
6. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2007; 27(6):710-5. PubMed ID: 18336100
[TBL] [Abstract][Full Text] [Related]
7. A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies.
Meyer-Schwesinger C; Meyer TN; Münster S; Klug P; Saleem M; Helmchen U; Stahl RA
J Pathol; 2009 Feb; 217(3):452-64. PubMed ID: 18985619
[TBL] [Abstract][Full Text] [Related]
8. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020.
Ahn W; Bomback AS
Am J Kidney Dis; 2020 Jun; 75(6):955-964. PubMed ID: 32331832
[TBL] [Abstract][Full Text] [Related]
9. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Chebotareva NV; Vinogradov A; Brzhozovskiy AG; Kashirina DN; Indeykina MI; Bugrova AE; Lebedeva M; Moiseev S; Nikolaev EN; Kononikhin AS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293475
[TBL] [Abstract][Full Text] [Related]
10. Morphological Features of Minimal Change Disease and Focal Segmental Glomerulosclerosis Using Repeat Biopsy and Parietal Epithelial Cell Marker.
Suzuki T; Kohatsu K; Han W; Watanabe S; Yahagi K; Nakata M; Ueno T; Ichikawa D; Imai N; Shirai S; Koike J; Shibagaki Y
Kidney Dis (Basel); 2020 Mar; 6(2):119-124. PubMed ID: 32309294
[TBL] [Abstract][Full Text] [Related]
11. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
Tune BM; Mendoza SA
J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855
[TBL] [Abstract][Full Text] [Related]
12. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
13. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
Park CW; Song HC; Shin YS; Ahn SJ; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK
Nephron; 1998; 79(1):44-9. PubMed ID: 9609461
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome].
Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Agraz I; Salcedo MT
Nefrologia; 2014; 34(1):46-52. PubMed ID: 24463862
[TBL] [Abstract][Full Text] [Related]
15. Ezrin--a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach.
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwinska A; Witt M
J Clin Pathol; 2006 Sep; 59(9):916-20. PubMed ID: 16522749
[TBL] [Abstract][Full Text] [Related]
16. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
[TBL] [Abstract][Full Text] [Related]
17. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
18. Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity.
Gonzalez Guerrico AM; Lieske J; Klee G; Kumar S; Lopez-Baez V; Wright AM; Bobart S; Shevell D; Maldonado M; Troost JP; Hogan MC;
Kidney Int Rep; 2020 Nov; 5(11):2021-2031. PubMed ID: 33163723
[TBL] [Abstract][Full Text] [Related]
19. [Study of urinary markers of different podocytopathies by proteomic analysis].
Vinogradov AA; Chebotareva NV; Bugrova AE; Brzhozovskiy AG; Krasnova TN; Nasibullina KZ; Kononikhin AS; Moiseev SV
Ter Arkh; 2023 Aug; 95(6):457-461. PubMed ID: 38158963
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of autoantibodies against ubiquitin carboxyl hydrolase L1 epitopes in the screening and diagnosis of Sjögren syndrome].
Li RR; Wang Y; Guo X; Li Y; Zhang LL; Meng Y; Ren HQ; He S; Lu RX; Zhu XL; Zhao R; Sun X
Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(33):2590-2595. PubMed ID: 36058683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
